Gaorav P Gupta

Title: Gaorav P Gupta: Innovator in Cancer Research

Introduction

Gaorav P Gupta is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of cancer research, particularly in understanding and mitigating the risks associated with breast cancer metastasis. With a total of 2 patents, his work is paving the way for innovative treatment options.

Latest Patents

One of Gaorav P Gupta's latest patents focuses on a method of predicting and reducing the risk of metastasis of breast cancer to the lung. This innovative approach establishes a signature for breast cancer tissue derived from a patient, which is indicative of the virulence and risk of lung metastasis. By determining the expression levels to define a sample signature and comparing it to a reference signature, appropriate treatment and monitoring options can be defined for the patient. The risk of metastasis can be reduced through a therapeutic combination that either inhibits epiregulin activity or targets proteins such as MMP1, MMP2, and PTGS2. Additionally, agents that inhibit the CXCL1 pathway can be utilized in these combinations.

Career Highlights

Gaorav P Gupta is affiliated with the Sloan Kettering Institute for Cancer Research, where he continues to advance his research in cancer treatment. His work is crucial in developing strategies that can significantly improve patient outcomes.

Collaborations

He has collaborated with notable colleagues in the field, including Joan Massague and Andy J Minn. These partnerships enhance the impact of his research and contribute to the collective effort in cancer innovation.

Conclusion

Gaorav P Gupta's contributions to cancer research through his innovative patents are vital in the ongoing battle against breast cancer metastasis. His work exemplifies the importance of research and collaboration in developing effective treatment strategies.